Marker Therapeutics Inc (MRKR) News

Marker Therapeutics Reports First Quarter 2019 Operating and Financial Results

Marker Therapeutics Reports First Quarter 2019 Operating and Financial Results --Company on track to submit...

Marker Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference

Marker Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference PR...

Current Report Filing (8-k)

      SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Confidential Treatment Order (ct Order)

Additional Proxy Soliciting Materials (definitive) (defa14a)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington...

Proxy Statement (definitive) (def 14a)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington...

Current Report Filing (8-k)

    SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM...

Marker Therapeutics Provides Business and Clinical Update

Marker Therapeutics Provides Business and Clinical Update --MultiTAA T cell therapies continue to demonstrate...

Marker Therapeutics to Host Business Update Conference Call and Webcast on Thursday, March 28th

Marker Therapeutics to Host Business Update Conference Call and Webcast on Thursday, March 28th PR...

Annual Report (10-k)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C...

Current Report Filing (8-k)

      SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Marker Therapeutics Announces Clinical Update at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019

Marker Therapeutics Announces Clinical Update at the Transplantation & Cellular Therapy Meetings of ASBMT...

Marker Therapeutics Congratulates Helen E. Heslop, MD, DSc (Hon) on Receiving the ASBMT Lifetime Achievement Award

Marker Therapeutics Congratulates Helen E. Heslop, MD, DSc (Hon) on Receiving the ASBMT Lifetime Achievement...

Marker Therapeutics to Present at the CAR-TCR Summit Europe

Marker Therapeutics to Present at the CAR-TCR Summit Europe PR Newswire HOUSTON, Feb. 20, 2019 HOUSTON, Feb...

Current Report Filing (8-k)

      SECURITIES AND EXCHANGE COMMISSION Washington, D.C...